In the just concluded week, Auris Medical Holding Ltd. (EARS) made the biggest weekly advance, gaining over 180%, thanks to positive in vitro efficacy data of AM-301 in protecting against SARS-CoV-2 infection.
A couple of stocks, say, Merrimack Pharmaceuticals Inc. (MACK), Codiak BioSciences Inc. (CDAK), Salarius Pharmaceuticals Inc. (SLRX), and Cellectar Biosciences Inc. (CLRB) registered gains in excess of 50% for the week.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.